BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21512274)

  • 21. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
    Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
    J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan.
    Choi B; Chun E; Kim M; Kim ST; Yoon K; Lee KY; Kim SJ
    J Clin Immunol; 2011 Apr; 31(2):253-64. PubMed ID: 20981478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Background data on NOD/Shi-scid IL-2Rγ
    Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
    J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
    Schueler J; Wider D; Klingner K; Siegers GM; May AM; Wäsch R; Fiebig HH; Engelhardt M
    PLoS One; 2013; 8(11):e79939. PubMed ID: 24223204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Anim; 2014; 63(3):289-96. PubMed ID: 25077758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
    PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
    Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
    J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
    Ito M; Kobayashi K; Nakahata T
    Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
    Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
    Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of liposome-encapsulated hemoglobin on human immune system: evaluation in immunodeficient mice reconstituted with human cord blood stem cells.
    Kawaguchi AT; Kametani Y; Kato S; Furuya H; Tamaoki K; Habu S
    Artif Organs; 2009 Feb; 33(2):169-76. PubMed ID: 19178463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
    J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
    Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
    PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
    Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
    Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
    Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
    Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) mice.
    Ishikawa Y; Usui T; Shiomi A; Shimizu M; Murakami K; Mimori T
    Eur J Immunol; 2014 Nov; 44(11):3453-63. PubMed ID: 25154613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
    Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
    Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.